
No data
No data
No data
| CAS Number | 137-58-6 |
| Catalog Number | AG003RA8(AGN-PC-0092MO) |
| Chemical Name | 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide |
| EC Number | 205-302-8 |
| IUPAC Name | 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide |
| InChI | InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17) |
| InChI Key | NNJVILVZKWQKPM-UHFFFAOYSA-N |
| MDL Number | MFCD00026733 |
| Molecular Formula | C14H22N2O |
| Molecular Weight | 234.3373 |
| NSC Number | 40030 |
| SMILES | C(C)N(CC(=O)NC1=C(C=CC=C1C)C)CC |
| UNII | 98PI200987 |
| Synonyms | 2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,
2-2EtN-2MePhAcN,
Dalcaine,
Lidocaine,
Lidocaine Carbonate,
Lidocaine Carbonate (2:1),
Lidocaine Hydrocarbonate,
Lidocaine Hydrochloride,
Lidocaine Monoacetate,
Lidocaine Monohydrochloride,
Lidocaine Monohydrochloride, Monohydrate,
Lidocaine Sulfate (1:1),
Lignocaine,
Octocaine,
Xylesthesin,
Xylocaine,
Xylocitin,
Xyloneural,
lidocaine,
137-58-6,
Lignocaine,
Xylocaine,
Lidoderm,
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide,
Anestacon,
Esracaine,
Duncaine,
Alphacaine,
Cappicaine,
Gravocain,
Isicaina,
L-Caine,
Leostesin,
Maricaine,
Xylocain,
Xylocitin,
Solcain,
Isicaine,
Xylestesin,
Rucaina,
Xilina,
Xycaine,
Xylotox,
Cito optadren,
Lida-Mantle,
Octocaine,
Dalcaine,
2-(Diethylamino)-2',6'-acetoxylidide,
Xyloneural (free base),
Cuivasil,
Dentipatch,
Jetocaine,
Lignocainum,
Remicaine,
Xilocaina,
Xllina,
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide,
Lidocaine (VAN),
Diethylaminoaceto-2,6-xylidide,
ELA-Max,
Xilocaina [Italian],
Dilocaine,
Lanabiotic,
Rocephin Kit,
Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-,
alpha-Diethylamino-2,6-dimethylacetanilide,
Lidocainum [INN-Latin],
Lidocaina [INN-Spanish],
EMBOLEX,
Lidocaine Carbonate,
2',6'-Acetoxylidide, 2-(diethylamino)-,
Xylocaine Viscous,
Lidocaton,
Xylocard,
Zingo,
alfa-Dietilamino-2,6-dimetilacetanilide,
CHEBI:6456,
HSDB 3350,
UNII-98PI200987,
Xylocaine (TN),
CHEMBL79,
EINECS 205-302-8,
NSC 40030,
LIDOPEN,
alfa-Dietilamino-2,6-dimetilacetanilide [Italian],
BRN 2215784,
C14H22N2O,
MLS000069724,
NNJVILVZKWQKPM-UHFFFAOYSA-N,
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide,
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide,
.alpha.-Diethylaminoaceto-2,6-xylidide,
NCGC00015611-10,
Xylesthesin,
Lidocaina,
Lidocaine, 97.5%,
Lidocainum,
SMR000058189,
.alpha.-(Diethylamino)-2,6-acetoxylidide,
.alpha.-Diethylamino-2,6-dimethylacetanilide,
.omega.-Diethylamino-2,6-dimethylacetanilide,
98PI200987,
DSSTox_CID_25166,
DSSTox_RID_80716,
DSSTox_GSID_45166,
N-(2,6-Dimethylphenyl)-N2,N2-diethylglycinamide,
2-(Diethylamino)-N-(2,6-Dimethylphenyl)ethanamide,
Lidocaine Hydrocarbonate,
Versatis,
Ztilido,
DermaFlex,
Anestacon Jelly,
Lidocaine Base,
Xylocaine-Mpf,
ZTlido,
Zilactin-L,
Lidocaine Monohydrochloride,
After Burn Gel,
Lidoject-1,
Lidoject-2,
After Burn Spray,
Xylocaine CO2,
Dentipatch (TN),
Octocaine-50,
CAS-137-58-6,
LQZ,
Lidocaine [USAN:INN:JAN],
Octocaine-100,
Xylocaine Test Dose,
Xylocaine Endotracheal,
Norwood Sunburn Spray,
Xylocaine 5% Spinal,
Xylocaine Dental Ointment,
Xylocaine-Mpf with Glucose,
Xyline,
Lignocaine base,
After Burn Double Strength Gel,
After Burn Double Strength Spray,
Lidocaine [USP:INN:BAN:JAN],
Lidocaine, powder,
2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide,
Zingo (Salt/Mix),
MFCD00026733,
Lidocaine(Alphacaine),
CDS1_000283,
Lidocaine (Alphacaine),
Spectrum_001118,
Lidothesin (Salt/Mix),
Xyloneural (Salt/Mix),
Opera_ID_385,
AC1L1GGQ,
Maybridge1_002571,
Prestwick0_000050,
Prestwick1_000050,
Prestwick2_000050,
Prestwick3_000050,
Spectrum2_001343,
Spectrum3_001392,
Spectrum4_000070,
Spectrum5_001549,
Lopac-L-5647,
Lidaform HC (Salt/Mix),
Epitope ID:116205,
Lidamantle HC (Salt/Mix),
2', 2-(diethylamino)-,
AC1Q2Z7J,
Neosporin Plus (Salt/Mix),
Lopac0_000669,
SCHEMBL15689,
BSPBio_000179,
BSPBio_001359,
BSPBio_003004,
KBioGR_000079,
KBioGR_000599,
KBioSS_000079,
KBioSS_001598,
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide,
4-12-00-02538 (Beilstein Handbook Reference),
MLS000758263,
MLS001074177,
MLS001423964,
N1-(2,6-dimethylphenyl)-N2,N2-diethylglycinamide,
ARONIS23855,
BIDD:GT0342,
Diethylaminoacet-2,6-xylidide,
DivK1c_000174,
DivK1c_001323,
Lidocaine, analytical standard,
Alphacaine;Xylocaine;lignocaine,
SPBio_001525,
SPBio_002100,
Lidocaine (JP17/USP/INN),
BPBio1_000197,
GTPL2623,
DTXSID1045166,
SCHEMBL17967359,
CTK3J2126,
HMS548M19,
KBio1_000174,
KBio2_000079,
KBio2_001598,
KBio2_002647,
KBio2_004166,
KBio2_005215,
KBio2_006734,
KBio3_000157,
KBio3_000158,
KBio3_002224,
ZINC20237,
Lidocaine 1.0 mg/ml in Methanol,
NINDS_000174,
Bio1_000379,
Bio1_000868,
Bio1_001357,
Bio2_000079,
Bio2_000559,
HMS1791D21,
HMS1989D21,
HMS2051C21,
HMS2089E15,
HMS2235O14,
HMS3371J04,
HMS3393C21,
HMS3428O07,
HMS3651G09,
BCP09081,
HY-B0185,
KS-000046GY,
NSC40030,
Tox21_110183,
ANW-42187,
BBL005525,
BDBM50017662,
LS-805,
NSC-40030,
s1357,
SBB080556,
STK552033,
AKOS001026768,
Tox21_110183_1,
CCG-100824,
CS-2070,
DB00281,
MCULE-9294700940,
NC00074,
RTR-031283,
SB19118,
Solarcaine aloe extra burn relief cream,
WLN: 2N2 & 1VMR B1 F1,
.alpha.-Diethylamino-2,6-acetoxylidide,
CAS-73-78-9,
IDI1_000174,
IDI1_033829,
NCGC00015611-01,
NCGC00015611-02,
NCGC00015611-03,
NCGC00015611-04,
NCGC00015611-05,
NCGC00015611-06,
NCGC00015611-07,
NCGC00015611-08,
NCGC00015611-09,
NCGC00015611-11,
NCGC00015611-12,
NCGC00015611-13,
NCGC00015611-14,
NCGC00015611-15,
NCGC00015611-16,
NCGC00015611-18,
NCGC00022176-05,
NCGC00022176-06,
NCGC00022176-07,
NCGC00022176-08,
NCGC00022176-09,
AC-10282,
AJ-08416,
AN-23138,
AS-13718,
CPD000058189,
M620,
SAM001247018,
SC-19460,
ST023341,
2-(Diethylamino)-2'',6''-acetoxylidide,
SBI-0050648.P004,
AB2000065,
TR-031283,
AB00053581,
FT-0082378,
FT-0600570,
L0156,
SW196598-4,
A18187,
C07073,
D00358,
J10173,
K-4450,
AB00053581-27,
AB00053581-28,
AB00053581_29,
AB00053581_30,
(2,6-dimethylphenyl)carbamoylmethyl-diethyl-azanium,
I01-2704,
N1-(2,6-dimethylphenyl)-2-(diethylamino)acetamide,
W-108233,
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide #,
BRD-K52662033-001-02-6,
BRD-K52662033-003-05-5,
BRD-K52662033-003-14-7,
Z55135799,
Lidocaine, British Pharmacopoeia (BP) Reference Standard,
Lidocaine, European Pharmacopoeia (EP) Reference Standard,
N~1~-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide,
Lidocaine, United States Pharmacopeia (USP) Reference Standard,
Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material,
Lidocaine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
91484-71-8,
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE); 6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE)),
Solarcaine,
Anbesol,
Xyloneural,
Emla Cream,
Oraqix,
Emla,
Neosporin Plus,
Lidamantle-HC,
Iontocaine,
Lingocaine,
Lidaform-HC,
Lidocaine hydrochloride,
Lidoderm Patch,
Mixture Name,
heparin-DHE,
heparin-dihydergot,
Mono-Embolex NM,
Lidocaine Monoacetate,
Oraqix (Salt/Mix),
SYNERA,
2,4-difluoropyridine,
LIDOCAINE HCL,
Lignocaine hydrochloride,
2-2EtN-2MePhAcN,
dihydroergotamine-heparin,
heparin-dihydroergotamine,
heparin-dihydergot 2500,
EMLA Cream (Salt/Mix),
D0X4RN,
Lidocaine Sulfate (1:1),
Lidocaine Carbonate (2:1),
Acetamide,6-dimethylphenyl)-,
L1026_SIGMA,
Lidocaine hydrochloride hydrate,
Lidocaine (JP15/USP/INN),
Lidocaine hydrochloride anhydrous,
CID3676,
alpha-Diethylaminoaceto-2,6-xylidide,
C14-H22-N2-O,
Solarcaine aloe extraburn relief cream,
Lidocaine, 99% - 100G 100g,
ACN-043204,
CS-O-01810,
alpha-(Diethylamino)-2,6-acetoxylidide,
Lidocaine Monohydrochloride, Monohydrate,
omega-Diethylamino-2,6-dimethylacetanilide,
A1450,
A10530,
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE),
C031388,
C511998,
D008012,
Acetamida, 2-(dietilamino)-N-(2,6-dimetilfenil)-,
''N''-(2,6-dimethylphenyl)-''N''2,''N''2-diethylglycinamide,
73-78-9,
34941-90-7,
|
| Complexity | 228 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 234.173g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 17 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 234.343g/mol |
| Monoisotopic Mass | 234.173g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 32.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H225-H301+H311+H331-H370-H302 |
| Packing Group | |
| Precautionary statements | P210-P260-P280-P301+P310-P311-P301+P312+P330 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

